Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced Levels of miR-145-3p Drive Cell Cycle Progression in Advanced High-Grade Serous Ovarian Cancer.
González-Cantó E, Monteiro M, Aghababyan C, Ferrero-Micó A, Navarro-Serna S, Mellado-López M, Tomás-Pérez S, Sandoval J, Llueca A, Herreros-Pomares A, Gilabert-Estellés J, Pérez-García V, Marí-Alexandre J. González-Cantó E, et al. Among authors: herreros pomares a. Cells. 2024 Nov 18;13(22):1904. doi: 10.3390/cells13221904. Cells. 2024. PMID: 39594652 Free PMC article.
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study).
Trozzi R, Tuyaerts S, Annibali D, Herreros Pomares A, Boog L, Van Dam P, Leunen K, Deroose C, Trum H, Amant F. Trozzi R, et al. Among authors: herreros pomares a. Int J Gynecol Cancer. 2024 Aug 5;34(8):1217-1224. doi: 10.1136/ijgc-2023-005229. Int J Gynecol Cancer. 2024. PMID: 38724237 Clinical Trial.
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD-1 blockade.
De Wispelaere W, Annibali D, Tuyaerts S, Messiaen J, Antoranz A, Shankar G, Dubroja N, Herreros-Pomares A, Baiden-Amissah REM, Orban MP, Delfini M, Berardi E, Van Brussel T, Schepers R, Philips G, Boeckx B, Baietti MF, Congedo L, HoWangYin KY, Bayon E, Van Rompuy AS, Leucci E, Tabruyn SP, Bosisio F, Mazzone M, Lambrechts D, Amant F. De Wispelaere W, et al. Among authors: herreros pomares a. Clin Transl Med. 2024 May;14(5):e1655. doi: 10.1002/ctm2.1655. Clin Transl Med. 2024. PMID: 38711203 Free PMC article.
Analgesic Efficacy and Safety of Intrathecal Morphine or Intercostal Levobupivacaine in Lung Cancer Patients after Major Lung Resection Surgery by Videothoracoscopy: A Prospective Randomized Controlled Trial.
González-Santos S, Mugabure B, Granell M, Aguinagalde B, López IJ, Aginaga A, Zubelzu I, Iraeta H, Zabaleta J, Izquierdo JM, González-Jorrín N, Sarasqueta C, Herreros-Pomares A. González-Santos S, et al. Among authors: herreros pomares a. J Clin Med. 2024 Mar 28;13(7):1972. doi: 10.3390/jcm13071972. J Clin Med. 2024. PMID: 38610735 Free PMC article.
Soluble galectin-3 as a microenvironment-relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma.
Torres-Martínez S, Calabuig-Fariñas S, Moreno-Manuel A, Bertolini G, Herreros-Pomares A, Escorihuela E, Duréndez-Saéz E, Guijarro R, Blasco A, Roz L, Camps C, Jantus-Lewintre E. Torres-Martínez S, et al. Among authors: herreros pomares a. Mol Oncol. 2024 Jan;18(1):190-215. doi: 10.1002/1878-0261.13505. Epub 2023 Nov 1. Mol Oncol. 2024. PMID: 37567864 Free PMC article.
Neutrophil Extracellular Traps and Cancer: Trapping Our Attention with Their Involvement in Ovarian Cancer.
Castaño M, Tomás-Pérez S, González-Cantó E, Aghababyan C, Mascarós-Martínez A, Santonja N, Herreros-Pomares A, Oto J, Medina P, Götte M, Mc Cormack BA, Marí-Alexandre J, Gilabert-Estellés J. Castaño M, et al. Among authors: herreros pomares a. Int J Mol Sci. 2023 Mar 22;24(6):5995. doi: 10.3390/ijms24065995. Int J Mol Sci. 2023. PMID: 36983067 Free PMC article. Review.
Increased levels of NETosis biomarkers in high-grade serous ovarian cancer patients' biofluids: Potential role in disease diagnosis and management.
Tomás-Pérez S, Oto J, Aghababyan C, Herranz R, Cuadros-Lozano A, González-Cantó E, Mc Cormack B, Arrés J, Castaño M, Cana F, Martínez-Fernández L, Santonja N, Ramírez R, Herreros-Pomares A, Cañete-Mota S, Llueca A, Marí-Alexandre J, Medina P, Gilabert-Estellés J. Tomás-Pérez S, et al. Among authors: herreros pomares a. Front Immunol. 2023 Feb 3;14:1111344. doi: 10.3389/fimmu.2023.1111344. eCollection 2023. Front Immunol. 2023. PMID: 36817483 Free PMC article.
24 results